Fei Su
- Co-authors
- Mikhail G. KoloninJohn DiGiovanniAchinto SahaAlexes C. DaquinagHirofumi ShounNaoki TakayaBrad SnyderZhan‐Guo Gao
- Topics
- Pharmacogenetics and Drug Metabolism (3 papers)Metabolism, Diabetes, and Cancer (3 papers)Drug Transport and Resistance Mechanisms (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of Molecular BiologyDevelopment
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fei Su
36 papers receiving 866 citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 472
- Cancer Research 239
- Oncology 210
- Pulmonary and Respiratory Medicine 137
- Physiology 116
Countries citing papers authored by Fei Su
This map shows the geographic impact of Fei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Su more than expected).
Fields of papers citing papers by Fei Su
This network shows the impact of papers produced by Fei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Su. The network helps show where Fei Su may publish in the future.
Co-authorship network of co-authors of Fei Su
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Su. A scholar is included among the top collaborators of Fei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Su. Fei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | Upregulation of STC2 in colorectal cancer and its clinicopathological significance | 4 |
| 4 | Survival benefit of higher fraction dose delivered by three-dimensional conformal radiotherapy in hepatocellular carcinoma smaller than 10 cm in size | 1 |
| 5 | 6 | |
| 6 | 30 | |
| 7 | 78 | |
| 8 | 29 | |
| 9 | 10 | |
| 10 | 6 | |
| 11 | 1 | |
| 12 | 136 | |
| 13 | 14 | |
| 14 | 38 | |
| 15 | 14 | |
| 16 | 35 | |
| 17 | 6 | |
| 18 | 13 | |
| 19 | 67 | |
| 20 | Fusion expression of green fluorescent protein and HCV capsid antigene in Escherichia coli cells. | 1 |
About Fei Su
Fei Su is a scholar working on Physiology, Cancer Research and Biotechnology, having authored 37 papers that have together received 879 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Cancer Research (239 citations), Oncology (210 citations) and Molecular Biology (472 citations). Fei Su has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Mikhail G. Kolonin, John DiGiovanni, Achinto Saha, Alexes C. Daquinag, Hirofumi Shoun, Naoki Takaya, Brad Snyder, Zhan‐Guo Gao, Lakshmi Reddy Bollu and Guang Gao. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Molecular Biology and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.